Uncategorized

Executive Order Seeks to Reduce Federal Regulations

A new executive order issued by the Trump administration calls for a significant reduction in federal regulations. Describing many current federal regulations as overly complex, burdensome, and obstacles to economic growth and innovation, the order directs that Unless prohibited by law, whenever an executive department or agency (agency) publicly proposes for notice and comment or otherwise promulgates a new regulation, it shall identify at least 10 existing regulations to be repealed. The executive order also states that For fiscal year 2025, which is in progress, the heads of all agencies are directed to ensure that the total incremental cost of [...]

joe2025-02-04T16:06:30-05:00February 5, 2025|Medicaid regulations, Medicare regulations, Uncategorized|

New Client

DeBrunner & Associates is pleased to welcome our newest client: the Delaware Healthcare Association. The Delaware Healthcare Association is a statewide trade and membership services organization that exists to represent and serve hospitals, health systems, and related health care organizations in their role of providing a continuum of appropriate, cost-effective, quality care to improve the health of the people of Delaware. The association views its primary role as that of serving as a leader in the promotion of effective change in health services through collaboration and consensus building on health care issues at the state and federal levels. Welcome Delaware [...]

joe2025-01-29T16:18:37-05:00January 30, 2025|Uncategorized|

New Client

DeBrunner & Associates is pleased to welcome our newest client: Maxim Healthcare Services. Maxim’s team of nurses, behavioral health therapists, caregivers, and other clinicians help patients of all ages maintain their quality of life in the comfort of their homes. Maxim specializes in private duty nursing (PDN), also known as continuous skilled-nursing (CSN) home care, for medically-complex and vulnerable patients under Medicaid. Many patients require assistive technology such as ventilators and tracheostomies to sustain life. Maxim is a national provider of home health care services, serving clients in 39 states and the District of Columbia. DeBrunner will consult with Maxim [...]

joe2024-11-19T16:28:49-05:00November 20, 2024|DeBrunner & Associates, Uncategorized|

HHS Acts on IV Shortage

The Department of Health and Human Services has initiated a series of steps to help restore the supply of IV solution that was greatly reduced by damage to a Baxter International Inc.’s facility in North Carolina during Hurricane Helene. Among those steps are: posting FDA guidance providing flexibility for compounding IV solution alternatives; extending the expiration dates of existing IV products; airlifting new supplies into and around the country; working with other manufacturers to increase production capacity; helping Baxter clean up and restore its North Carolina plant and invoking the Defense Production Act toward that end; and more. Learn more [...]

joe2024-10-15T17:30:39-04:00October 16, 2024|Uncategorized|

Administration Launches Patient Safety Initiatives

In response to World Patient Safety Day, the administration has launched a multi-faceted approach to reducing harm for patients and workers in the delivery of health care. The initiative will fall under the umbrella of a new multi-agency, public/private National Action Alliance for Patient and Workforce Safety administered by the Department of Health and Human Services’ Agency for Health Care Research and Quality. Other federal agencies to be involved in the initiative include the Centers for Disease Control and Prevention, the Centers for Medicare & Medicaid Services, the Veterans Health Administration, the Department of Defense, the Health Resources and Services [...]

joe2024-09-19T17:44:03-04:00September 23, 2024|Centers for Medicare & Medicaid Services, Uncategorized|

Court Rejects Non-Compete Ban

A federal court has rejected a Federal Trade Commission regulation that banned non-compete agreements between employers and employees under most circumstances. In a suit brought in Texas by the U.S. Chamber of Commerce, the Business Roundtable, the Texas Association of Business, and others, the court found that the FTC exceeded its authority in promulgating the regulation and that the rule itself was “arbitrary and capricious,” based on limited evidence, and without either a rationale for such a sweeping approach nor any evidence that the agency considered a more limited approach to the challenges it identified as the basis for advancing [...]

joe2024-08-21T11:42:58-04:00August 21, 2024|Uncategorized|

Court Sides Again With Providers on No Surprises Act

A federal appellate court has affirmed a lower court ruling that the manner in which federal regulations tell No Surprises Act dispute arbiters to evaluate competing fee claims unfairly favors health care payers over providers. At issue is a regulatory directive that arbiters weigh what is known as the qualifying payment amount – the median of what insurers contract to pay providers in a given geographic area – when deciding on payments. In February a federal court ruled that using this measure in what is known as the independent dispute resolution process unfairly stacked the arbitration process in favor of [...]

joe2024-08-08T16:52:09-04:00August 12, 2024|Uncategorized|

The “Other” Supreme Court Decision

While much attention has focused on recent Supreme Court decisions involving reproductive care rights and presidential immunity, a less-noticed case has potential implications for the health care industry. In the case of Securities and Exchange Commission v. Jarkesy, the Supreme Court ruled last week that the SEC’s use of administrative proceedings to levy a fine against a hedge fund manager for misleading investors deprived that manager of the right to a court trial. While the immediate ruling addresses only the SEC case, the underlying rationale has implications across the federal government – including health care agencies. Currently, the Department of [...]

joe2024-07-03T16:18:15-04:00July 5, 2024|Uncategorized|

The Times Looks at PBMs

The New York Times this week began an in-depth look at pharmacy benefit managers: the companies that administer the prescription drug benefits of more than 200 million Americans. As the Times notes, only three companies dominate the market, and its report examines when, how, and if PBMs save money for insurers and consumers; how they charge for prescription drugs; how they influence consumer access to prescription drugs – and the timeliness of that access; the effect they are having on independent pharmacies; how they make money; the influence they have on the price of prescription drugs; and more. Learn more [...]

joe2024-06-25T19:58:47-04:00June 26, 2024|Uncategorized|

Federal Health Policy Update for March 21

The following is the latest health policy news from the federal government for March 15-21. Some of the language used below is taken directly from government documents. The White House The White House has announced new actions to advance women’s health research and innovation and issued an executive order in support of that objective. The order directs executive branch agencies to integrate women’s health across the federal research portfolio; prioritize investments in women’s health research; pursue new research on women’s midlife health; and assess unmet needs to support women’s health research. Learn more from this White House fact sheet, which [...]